Mimedx (MDXG) EBIT (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -176.14% |
| Dec 31, 2025 | -5.02% |
| Sep 30, 2025 | 79.39% |
| Jun 30, 2025 | 49.92% |
| Mar 31, 2025 | -25.36% |
| Dec 31, 2024 | -0.97% |
| Sep 30, 2024 | -52.40% |
| Jun 30, 2024 | 77.68% |
| Mar 31, 2024 | -14.80% |
| Dec 31, 2023 | 39.25% |
| Sep 30, 2023 | 2.63% |
| Jun 30, 2023 | 3,287.94% |
| Mar 31, 2023 | -103.01% |
| Dec 31, 2022 | 259.24% |
| Sep 30, 2022 | 26.29% |
| Jun 30, 2022 | -3.61% |
| Mar 31, 2022 | -823.74% |
| Dec 31, 2021 | 219.53% |
| Sep 30, 2021 | -162.20% |
| Jun 30, 2021 | 94.02% |
| Mar 31, 2021 | 57.42% |
| Dec 31, 2020 | -65.77% |
| Sep 30, 2020 | -65.76% |
| Jun 30, 2020 | 57.39% |
| Mar 31, 2020 | -182.10% |
| Dec 31, 2019 | -134.31% |
| Sep 30, 2019 | 183.16% |
| Jun 30, 2019 | -27.29% |
| Mar 31, 2019 | -50.00% |
| Dec 31, 2018 | -2,497.32% |
| Sep 30, 2018 | -77.73% |
| Jun 30, 2018 | -43.62% |
| Mar 31, 2018 | -87.61% |
| Dec 31, 2017 | 171.23% |
| Sep 30, 2017 | 22.58% |
| Jun 30, 2017 | 16.62% |
| Mar 31, 2017 | 169.91% |
| Dec 31, 2016 | -288.11% |
| Sep 30, 2016 | 32.07% |
| Jun 30, 2016 | 142.74% |
| Mar 31, 2016 | -81.07% |
| Dec 31, 2015 | 15.45% |
| Sep 30, 2015 | 18.79% |
| Jun 30, 2015 | 33.08% |
| Mar 31, 2015 | -8.71% |
| Dec 31, 2014 | 24.69% |
| Sep 30, 2014 | 1,051.79% |
| Jun 30, 2014 | 56.00% |
| Mar 31, 2014 | 36.90% |
| Dec 31, 2013 | -451.80% |
| Sep 30, 2013 | 65.62% |
| Jun 30, 2013 | -228.01% |
| Mar 31, 2013 | 76.67% |
| Dec 31, 2012 | 73.25% |
| Sep 30, 2012 | -2,992.96% |
| Jun 30, 2012 | 81.39% |
| Mar 31, 2012 | 74.08% |
| Dec 31, 2011 | -47.42% |
| Sep 30, 2011 | 31.62% |
| Jun 30, 2011 | 25.79% |